Design of Novel Chemotherapeutic Agents Targeting Checkpoint Kinase 1 Using 3D-QSAR Modeling and Molecular Docking Methods

Publisher： Bentham Science Publishers

E-ISSN： 1875-6697|12|4|302-313

ISSN： 1573-4099

Source： Current Computer - Aided Drug Design, Vol.12, Iss.4, 2016-12, pp. : 302-313

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacophore Based 3D-QSAR Modeling and Molecular Docking of Leucettines as Potent Dyrk1A Inhibitors

By  

Letters in Drug Design & Discovery, Vol. 10, Iss. 8, 2013-10 ,pp. : 719-726

Bentham Science Publishers

Access to resources Recommend Favorite

Searching for Novel Janus Kinase-2 Inhibitors Using a Combination of Pharmacophore Modeling, 3D-QSAR Studies and Virtual Screening

By  

Mini Reviews in Medicinal Chemistry, Vol. 17, Iss. 3, 2017-01 ,pp. : 268-294

Bentham Science Publishers

Access to resources Recommend Favorite

Possible Binding Mode Analysis of Pyrazolo-triazole Hybrids as Potential Anticancer Agents through Validated Molecular Docking and 3D-QSAR Modeling Approaches

By  

Letters in Drug Design & Discovery, Vol. 14, Iss. 5, 2017-04 ,pp. : 515-527

Bentham Science Publishers

Access to resources Recommend Favorite

3D-QSAR and Molecular Docking Studies of HIV-1 Entry Inhibitors Targeting GP120-CD4 Binding Site

By  

Anti-Infective Agents, Vol. 15, Iss. 2, 2018-01 ,pp. : 115-130

Bentham Science Publishers

Access to resources Recommend Favorite

Identification of Novel IRAK-4 Inhibitors Through Pharmacophore Modeling, Atom-based 3D-QSAR, Docking Strategies and Molecular Dynamics Simulation

By  

Letters in Drug Design & Discovery, Vol. 13, Iss. 9, 2016-11 ,pp. : 879-887

Bentham Science Publishers

Access to resources Recommend Favorite